Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers track elusive brain tumor cells in mice with neural stem cells modified to deliver IL-12

15.10.2002


Findings are cover story of Oct. 15 issue of Cancer Research



Researchers at Cedars-Sinai Medical Center’s Maxine Dunitz Neurosurgical Institute have successfully tested a new treatment for brain cancer by utilizing neural stem cells to track and destroy cancer cells within the brain. Scientists hope the encouraging results may eventually lead to an effective treatment for glioma, the most aggressive form of primary brain tumor in humans. The study, conducted in mice with experimental brain cancer, is featured on the cover of the Oct. 15 issue of the journal Cancer Research.

The prognosis has historically been extremely poor for patients diagnosed with malignant gliomas. These tumors have very poorly defined margins, and glioma cells often spread deep into healthy brain tissue making their effective surgical removal extremely difficult. Often, pockets of tumor cells break off from the main tumor and migrate deep into non-tumorous areas of the brain. Therefore, even if the original tumor is completely removed or destroyed, the risk of recurrence is high as cells in these distant "satellites" multiply and eventually re-form a new brain tumor. Due to these characteristics, treating brain cancer has been extremely difficult.


The new experimental treatment involves the use of neural stem cells for tracking and targeting brain tumor cells that spread out into normal brain. Scientists show that neural stem cells, when injected into brain tumors, can follow tumor cells as they migrate away from the main tumor mass. This capability led scientists to genetically engineer neural stem cells to produce interleukin 12, an immune stimulating chemical known to kill glioma cells. The interleukin 12 producing neural stem cells were then injected into brain tumors in mice and could kill tumor cells that had spread deep into normal brain tissue, at considerable distance from the primary tumor. Mice treated with this novel strategy survived significantly longer than control-treated mice. In fact, 30% of animals treated in this new manner developed long-term immunity to brain cancer, indicating the potency of this therapy.

Scientists demonstrated that the neural stem cells were able to kill the spreading tumor cells by delivering interleukin 12 directly to these migrating glioma "satellites". Previous research at the Maxine Dunitz Neurosurgical Institute has demonstrated that interleukin 12 can activate cancer killing cells from the immune system to attack and destroy brain tumor cells. The ability of neural stem cells to deliver this immune stimulating protein directly to small pockets of brain tumor cells that can not be accessed using surgery, represents a promising new method that could be used to eliminate all remaining tumor left behind after routine surgery. This could hopefully lower the incidence of tumor recurrence and improve survival in patients with malignant gliomas.

"The current focus of experimental neural stem cell therapeutics is primarily based around their use in the treatment of neurodegenerative disorders and stroke. We have demonstrated that combining the tumoricidal potency of interleukin 12 with the extensive tumor tracing capability of neural stem cells, results in a synergistic therapeutic benefit," according to the authors. "This further extends the scope of neural stem cell therapy to include their use as vehicles for protein delivery to in vivo glioma, and therefore represents a promising new treatment modality for malignant brain tumors."

Sandra Van | EurekAlert!
Further information:
http://www.csmc.edu/

More articles from Health and Medicine:

nachricht How cancer metastasis happens: Researchers reveal a key mechanism
19.01.2018 | Weill Cornell Medicine

nachricht Researchers identify new way to unmask melanoma cells to the immune system
17.01.2018 | Duke University Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Artificial agent designs quantum experiments

On the way to an intelligent laboratory, physicists from Innsbruck and Vienna present an artificial agent that autonomously designs quantum experiments. In initial experiments, the system has independently (re)discovered experimental techniques that are nowadays standard in modern quantum optical laboratories. This shows how machines could play a more creative role in research in the future.

We carry smartphones in our pockets, the streets are dotted with semi-autonomous cars, but in the research laboratory experiments are still being designed by...

Im Focus: Scientists decipher key principle behind reaction of metalloenzymes

So-called pre-distorted states accelerate photochemical reactions too

What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...

Im Focus: The first precise measurement of a single molecule's effective charge

For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.

Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...

Im Focus: Paradigm shift in Paris: Encouraging an holistic view of laser machining

At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.

No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...

Im Focus: Room-temperature multiferroic thin films and their properties

Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.

Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

10th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Münster, 10-11 April 2018

08.01.2018 | Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

 
Latest News

Thanks for the memory: NIST takes a deep look at memristors

22.01.2018 | Materials Sciences

Radioactivity from oil and gas wastewater persists in Pennsylvania stream sediments

22.01.2018 | Earth Sciences

Saarland University bioinformaticians compute gene sequences inherited from each parent

22.01.2018 | Life Sciences

VideoLinks Wissenschaft & Forschung
Overview of more VideoLinks >>>